Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12926
CALL
Invesco S&P 500 Pure Value ETF
RPV
$1.75B
| $27.1K | ﹤0.01% |
300
| – | – |
|
12927
CALL
YieldMax AAPL Option Income Strategy ETF
APLY
$117M
| $27.1K | ﹤0.01% |
+1,500
| New | +$26.9K |
|
|
EPIX
12928
PUT
DELISTED
ESSA Pharma
EPIX
| $27K | ﹤0.01% |
15,100
-5,900
| -28% | -$18.8K |
|
12929
PUT
Future Fuel
FF
$245M
| $27K | ﹤0.01% |
5,100
-1,400
| -22% | -$7.81K |
|
12930
Grupo Cibest SA
CIB
$22.8B
| $27K | ﹤0.01% |
856
-38,693
| -98% | -$1.25M |
|
12931
PUT
Helios Technologies
HLIO
$2.69B
| $26.8K | ﹤0.01% |
600
-1,200
| -67% | -$59.4K |
|
12932
PUT
Clene
CLNN
$52.9M
| $26.7K | ﹤0.01% |
+5,035
| New | +$25.3K |
|
12933
CALL
iShares Fallen Angels USD Bond ETF
FALN
$1.61B
| $26.7K | ﹤0.01% |
+1,000
| New | +$27K |
|
12934
CALL
Banner Corp
BANR
$2.52B
| $26.7K | ﹤0.01% |
+400
| New | +$27.3K |
|
12935
PUT
Mercantile Bank Corp
MBWM
$1.06B
| $26.7K | ﹤0.01% |
600
+100
| +20% | +$4.65K |
|
12936
CALL
ESCO Technologies
ESE
$7.92B
| $26.6K | ﹤0.01% |
200
| – | – |
|
12937
PUT
Hooker Furnishings Corp
HOFT
$158M
| $26.6K | ﹤0.01% |
+1,900
| New | +$32K |
|
12938
PUT
Black Diamond Therapeutics
BDTX
$116M
| $26.5K | ﹤0.01% |
12,400
-76,000
| -86% | -$218K |
|
12939
PUT
Atlantic Union Bankshares
AUB
$6.12B
| $26.5K | ﹤0.01% |
700
-1,400
| -67% | -$55.5K |
|
12940
Intensity Therapeutics
INTS
$12.9M
| $26.5K | ﹤0.01% |
+599
| New | +$43.5K |
|
12941
CALL
Shenandoah Telecom
SHEN
$735M
| $26.5K | ﹤0.01% |
2,100
-600
| -22% | -$8.07K |
|
12942
CALL
CLPS Inc
CLPS
$25.8M
| $26.4K | ﹤0.01% |
23,000
+18,400
| +400% | +$22.7K |
|
12943
Talphera
TLPH
$63.8M
| $26.4K | ﹤0.01% |
+50,449
| New | +$39.4K |
|
12944
Destination XL Group
DXLG
$35.4M
| $26.3K | ﹤0.01% |
9,783
-54,664
| -85% | -$147K |
|
12945
CALL
Sensus Healthcare
SRTS
$47.1M
| $26.3K | ﹤0.01% |
3,800
+1,700
| +81% | +$12.5K |
|
12946
PUT
Varex Imaging
VREX
$779M
| $26.3K | ﹤0.01% |
1,800
-8,300
| -82% | -$116K |
|
|
AAT
12947
CALL
American Assets Trust
AAT
$1.4B
| $26.3K | ﹤0.01% |
1,000
-6,000
| -86% | -$164K |
|
12948
CALL
Kopin
KOPN
$1.02B
| $26.2K | ﹤0.01% |
19,300
-33,100
| -63% | -$31.8K |
|
12949
PUT
Exagen
XGN
$161M
| $26.2K | ﹤0.01% |
6,400
+6,000
| +1,500% | +$21.6K |
|
12950
PUT
Fate Therapeutics
FATE
$308M
| $26.2K | ﹤0.01% |
15,900
+6,900
| +77% | +$17.4K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.